These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18835045)

  • 81. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fluctuations of CD4+ T-cell subsets in remitting-relapsing multiple sclerosis.
    Rose LM; Ginsberg AH; Rothstein TL; Ledbetter JA; Clark EA
    Ann Neurol; 1988 Aug; 24(2):192-9. PubMed ID: 2972250
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis.
    Saxena A; Martin-Blondel G; Mars LT; Liblau RS
    FEBS Lett; 2011 Dec; 585(23):3758-63. PubMed ID: 21910991
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis.
    Baughman EJ; Mendoza JP; Ortega SB; Ayers CL; Greenberg BM; Frohman EM; Karandikar NJ
    J Autoimmun; 2011 Mar; 36(2):115-24. PubMed ID: 21257291
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 86. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy.
    Corrigan CJ; Haczku A; Gemou-Engesaeth V; Doi S; Kikuchi Y; Takatsu K; Durham SR; Kay AB
    Am Rev Respir Dis; 1993 Mar; 147(3):540-7. PubMed ID: 8095124
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.
    Lécuroux C; Girault I; Boutboul F; Urrutia A; Goujard C; Meyer L; Lambotte O; Chaix ML; Martinez V; Autran B; Sinet M; Venet A; ; ;
    AIDS; 2009 Aug; 23(13):1649-58. PubMed ID: 19617814
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Conversion of peripheral CD4(+)CD25(-) T cells to CD4(+)CD25(+) regulatory T cells by IFN-gamma in patients with Guillain-Barré syndrome.
    Huang S; Li L; Liang S; Wang W
    J Neuroimmunol; 2009 Dec; 217(1-2):80-4. PubMed ID: 19853929
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Expression of adhesion molecules on peripheral lymphocytes predicts future lesion development in MS.
    Eikelenboom MJ; Killestein J; Izeboud T; Kalkers NF; Baars PA; van Lier RA; Barkhof F; Uitdehaag BM; Polman CH
    J Neuroimmunol; 2005 Jan; 158(1-2):222-30. PubMed ID: 15589057
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
    Fierro MT; Novelli M; Quaglino P; Comessatti A; Fava P; Ortoncelli M; Ponti R; Bernengo MG
    Dermatology; 2008; 216(3):213-21. PubMed ID: 18182812
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study.
    Putzki N; Kumar M; Kreuzfelder E; Grosse-Wilde H; Diener HC; Limmroth V
    Eur Neurol; 2009; 61(1):27-32. PubMed ID: 18948697
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Analysis of effector CD4 (OX-40+) and CD8 (CD45RA+CD27-) T lymphocytes in active multiple sclerosis.
    Hintzen RQ; Pot K; Paty D; Oger J
    Acta Neurol Scand; 2000 Jan; 101(1):57-60. PubMed ID: 10660154
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CD4+ CD25+ T-regulatory cells in psoriasis. Correlation between their numbers and biologics-induced clinical improvement.
    Richetta AG; Mattozzi C; Salvi M; Giancristoforo S; D'epiro S; Milana B; Carboni V; Zampetti M; Calvieri S; Morrone S
    Eur J Dermatol; 2011; 21(3):344-8. PubMed ID: 21680285
    [TBL] [Abstract][Full Text] [Related]  

  • 95. CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatment.
    Jensen J; Langkilde AR; Frederiksen JL; Sellebjerg F
    J Neuroimmunol; 2006 Oct; 179(1-2):163-72. PubMed ID: 16919783
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Changes in the percentage of activated lymphocytes in bronchoalveolar lavage fluid in patients with clinical improvement of sarcoidosis].
    Piesiak P; Jankowska R; Passowicz-Muszyńska E
    Wiad Lek; 2006; 59(9-10):644-8. PubMed ID: 17338122
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Glatiramer acetate-specific human CD8(+) T cells: increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment.
    Dressel A; Vogelgesang A; Brinkmeier H; Mäder M; Weber F
    J Neuroimmunol; 2006 Dec; 181(1-2):133-40. PubMed ID: 17084909
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Changes of subtype T lymphocytes in blood after implanting with xenogeneic acellular bone matrix].
    Sun X; Wang Z; Zhu P
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Apr; 19(4):322-5. PubMed ID: 15921329
    [TBL] [Abstract][Full Text] [Related]  

  • 99. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.
    Mizukawa Y; Yamazaki Y; Shiohara T
    Br J Dermatol; 2008 Jun; 158(6):1230-8. PubMed ID: 18363767
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: long-term protective effects and enhanced efficacy of methylprednisolone formulations.
    Linker RA; Weller C; Lühder F; Mohr A; Schmidt J; Knauth M; Metselaar JM; Gold R
    Exp Neurol; 2008 Jun; 211(2):397-406. PubMed ID: 18394606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.